These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1370180)

  • 1. G-CSF for fever and neutropenia induced by chemotherapy.
    Hamm JT
    N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Small cell lung cancer: value of G-CSF].
    Trillet V
    Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF reduces incidence of chemotherapy-associated infections.
    Oncology (Williston Park); 1990 Aug; 4(8):12. PubMed ID: 1698430
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.
    Pujol JL; Tabah I; Michel FB
    Pathol Biol (Paris); 1992 Nov; 39(9):960. PubMed ID: 1311449
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines in cancer chemotherapy: present state and problems in use of G- and GM-CSF for solid tumors in Japan].
    Ogawara M
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):164-70. PubMed ID: 9474924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
    Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
    J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF for fever and neutropenia induced by chemotherapy.
    Auchter RM
    N Engl J Med; 1992 Jan; 326(4):269-70. PubMed ID: 1370183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of hematopoietic growth factors in bronchial cancerology].
    Lemarié E; Milleron B
    Rev Mal Respir; 1995; 12(5):429-34. PubMed ID: 8560073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: need for economical studies.
    Urban T; Lebeau B
    Eur Respir J; 1999 Jun; 13(6):1228-9. PubMed ID: 10445594
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
    Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
    Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
    An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
    Bronchud M; Scarffe JH; Thatcher N; Crowther D; Souza LM; Alton NK; Testa NG; Dexter TM
    Behring Inst Mitt; 1988 Aug; (83):327-9. PubMed ID: 2467655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.